New Insurance and Protection logo
,

9 in 10 life cover applications with mental health disclosures instantly accepted on the underwriter protection platform in 2024

I

UnderwriteMe, the Insurtech company of Pacific Life Re, has revealed that 90% of life cover applications with mental health disclosures were instantly accepted on its Protection Platform in 2024. The findings are taken from UnderwriteMe’s Protection Platform Pulse Report that is released today.

The report is based on an analysis of data from UnderwriteMe’s Protection Platform. UnderwriteMe partners with a number of leading insurers including HSBC Life, LV=, Royal London, Scottish Widows and Vitality. The anonymised and aggregated data is taken from applications submitted and purchased on the platform across all providers throughout 2024. 

Further findings from the report reveal that there are an average of 1.16 disclosures per customer, the data suggests that a number of applicants disclose existing health conditions or lifestyle factors that require underwriting consideration. Furthermore, the demand for bundled protection is rising with an average of 1.4 products per application.

Straight-through processing 

The Protection Platform Pulse Report analysed straight-through processing rates, which revealed life cover stands at 85% and critical illness (CI) at 80% for all applications. The rising trend in life cover and life with CI submissions signals a growing demand for comprehensive coverage solutions. Straight through processing for income protection (IP) remains at an average 62% (2023 and 2024). 

Andrew Doran, CEO of UnderwriteMe commented: “The Protection Platform continues to offer highly competitive STP rates year-on-year, with Life Cover at 85% and Life Cover with Critical Illness (CI) at 80%, indicating a competitive market where underwriting efficiency is key. The slight rising trend in Life Cover and Life with CI submissions signals growing demand for comprehensive coverage solutions. Additionally, STP for Income Protection (IP) remain at an average 62%, which is due to IP underwriting being more complex than Life Cover products.

“While the volume of placed applications is important, straight-through processing (STP) rates remain a key measure of efficiency, and a deeper understanding of disclosure trends can drive better outcomes for both advisers and customers. In a highly competitive market, where clients expect speed and convenience, high STP rates provide advisers with a significant advantage — streamlining the buying process, improving client satisfaction, and ultimately driving more business growth.”

‘Buy now’ decisions 

Looking at ‘buy now’ decision rates, depression, anxiety and stress are the most common health conditions that receive instant acceptance across life insurance, critical illness (CI) and income protection (IP) applications. These positive ‘buy now’ decisions demonstrate how the Protection Platform enables advisers to protect more lives confidently and quickly. 

Below is an overview of the most frequent disclosures across life cover and critical illness cover, along with their respective buy-now decision rates. 

Tom Conner, Strategy Development Director at Drewberry commented: “Protection advisers know that when a case is referred to underwriting the process can often be long – sometimes many months, which is time consuming and costly. In some situations clients lose interest during the underwriting process and contacting them with a higher premium once they’ve lost interest can be a lost cause. 

“Protection is not at the top of most peoples’ minds so when they do contact us, we need to be able to deliver solutions as quickly as possible. Systems that provide ‘buy-now’ functionality is essential for protection advisers where cases have certain underwriting issues and it’s great to see so many non-standard applications being accepted.”

Life insurance 

Disclosure Buy-Now Decision Rate (Up To)
Depression, anxiety, stress90%
Raised blood pressure87%
Asthma99%
Cholesterol80%
Diabetes71%
Back pain99%
Irritable Bowel Syndrome95%
Cystitis92%
Osteoarthritis97%
Hypothyroidism95%

Critical illness (CI)

Disclosure Buy-Now Decision Rate (Up To)
Depression, anxiety, stress93%
Back pain99%
Asthma99%
Raised blood pressure90%
Cholesterol81%
Abnormal cervical smear75%
Cystitis91%
Irritable Bowel Syndrome94%
Osteoarthritis98%
Hypothyroidism91%

Andrew Doran, CEO of UnderwriteMe continued: “Over the past year, the life and protection insurance industry has gone through significant shifts. From provider mergers to rising living costs, evolving customer expectations, and increasing regulations, it’s becoming increasingly challenging for advisers to navigate a rapidly changing landscape. However, the findings in our Protection Platform Pulse Report are a positive sign and highlight not just UnderwriteMe’s strengths but the industry’s move toward more inclusive underwriting.”

Britney Trussler, Protection Manager at Dynamo commented: “The most common disclosures we encounter include high blood pressure, high cholesterol, diabetes, and mental health conditions and we frequently see a high rate of instant decisions from UnderwriteMe, provided recent medical readings are within normal or slightly elevated ranges. 

“This is a significant advantage for advisers who help clients with underwriting issues as we can offer provide cover in the same time frame as those with a clean bill of health. Instant decisions for clients with pre-existing conditions significantly reduce the time advisers spend seeking indications from multiple providers, offering immediate reassurance and greater efficiency.”

Related Articles

Sign up to the Insurance & Protection Newsletter

Please enable JavaScript in your browser to complete this form.
Name

Trending Articles


Podcast Insurance and Protection
IFA Talk logo

IFA Talk Insurance and Protection is the new addition to the IFA Talk podcast family, where we discuss the latest topics relevant to Insurance and Protection professionals.

IFA Talk Insurance & Protection Podcast – latest episode

IFA Magazine
Privacy Overview

Our website uses cookies to enhance your experience and to help us understand how you interact with our site. Read our full Cookie Policy for more information.